IMMUCELL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.81 USD | +0.21% |
|
-11.58% | -5.50% |
| 05-15 | Transcript : ImmuCell Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
| 04-09 | Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 37.63M | - | - | - | - | - | |
| 50.93B | - | |||||
| 42.12B | ||||||
| 42.05B | ||||||
| 29.18B | ||||||
| 26.02B |
